pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·Aug 24·1 min read
save

Qiagen names Jonathan M. Pratt as new chief executive after nine-month search

Aug 24, 2026·read at Fierce Biotech ↗Neutral

Qiagen announced that Jonathan M. Pratt will take over as chief executive, ending a nine‑month search for a successor.

Pratt arrives from Filtration Group, where he served as president and CEO. He has also held senior positions at Waters Corporation and Beckman Coulter Life Sciences.

In his introductory remarks, Pratt said his first priority is to listen to Qiagen teams and customers, sharpen the company’s choices, strengthen execution and create greater impact.

The appointment follows the unexpected departure of long‑term CEO Thierry Bernard, who stepped down after six years. Bernard’s tenure included a near‑acquisition by Thermo Fisher in 2020 that ultimately collapsed.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Qiagen appoints new chief executive after 9-month search”

read at Fierce Biotech ↗
307 words · retrieved Aug 24
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Diagnostics Company4Medical Device Company3OphthalmologyPulmonology

related stories

  • Sep 24Grail multicancer detection test wins FDA advisers’ backingBioPharma Dive
  • Sep 24Grail survives adcomm vote as it awaits FDA decision for cancer blood testFierce Biotech
  • Sep 18FDA clears Aptitude’s latest Metrix molecular dx to test for COVIDFierce Biotech
  • Aug 18STAT+: Real-world psilocybin data suggest need for close monitoringSTAT
  • Aug 17How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and MedicineBioSpace